Home >> Report Store >> Healthcare >> Antibiotics Market, By Inhibitor Types (Protein Synthesis, Cell Wall, >
Antibiotics Market Size Worth $59.6 Billion By 2025 | CAGR: 4.9%

Published Date : 09 / 05 / 18  | Report Format: PDF

The global antibiotics market is expected to grow at growth rate of 4.9% to reach USD 59.6 billion by 2025.

Rising prevalence of infectious and chronic diseases drive the market growth to great extent. For example, according to the Epidemiology & Community Health Research, infectious diseases remain one of the most important causes of mortality and morbidity across the globe. This would, in turn, increase the demand for antibiotics, driving the market growth. In addition, rising approval of novel and effective antibiotics by government organizations drive the market growth. For example, in February 2015, AstraZeneca’s Ceftazidime-avibactam (Avycaz) was approved by the U.S. FDA for the treatment of complicated intra-abdominal (cIAI) infections. Similarly, in May 2014, the U.S. FDA approved Dalbavancin (Dalvance) for the treatment of acute bacterial skin and skin structure infections. All such factors, along with, rising geriatric population, advancement in technologies, and increasing demand for effective therapeutics are driving the industry demand. However, stringent regulatory policies, high research and development cost and growing concern over antibiotic overuse are likely to hamper the market growth over the future period.

Key Takeaways

  • Of the different inhibitor types, cell wall synthesis segment accounted for the highest share of the total market. In 2017, the segment captured around 42% share and is projected to dominate the industry.
  • RNA segment is projected to grow with the highest growth rate and is pegged to register a 6.2% CAGR in terms of value.
  • Drug class is categorized into Cephalosporin, Fluoroquinolones, Macrolides, Carbapenems, Penicillin, Aminoglycosides, and other. Among which, cephalosporin is the highest revenue generating segment throughout the study period.
  • Geographically, Asia Pacific region is accounted for the largest share. Whereas, regions such as North America and European countries are growing with the strong growth rate during the foreseeable future.
  • Novartis AG, Johnson & Johnson, Pfizer, Inc., GlaxoSmithKline, Bayer AG, and AstraZeneca are profiled in detail with the attributes such as company overview, financial performance, and key developments.
  • Strategic collaborations are one of the most important strategies adopted by key players to expand their presence. For instance, in November 2017, Melinta Therapeutics, Inc. privately held novel broad-spectrum antibiotics developer, acquired the Medicines Company. This acquisition has helped Melinta to expand its product portfolio by addition Medicines’ marketed products such as Orbactiv (oritavancin), Vabomere (vaborbactam/meropenem), and Minocin IV (minocycline).


  • In-depth analysis of the key market dynamics
  • Granular analysis of the current market scenario and expected factors to affect the market
  • Detailed analysis of the geographic region, regional and county wise analysis
  • Highlight on the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the market

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation


  • Protein Synthesis Inhibitors
  • Cell Wall Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Others


  • Fluoroquinolones
  • Cephalosporin
  • Penicillin
  • Macrolides
  • Carbapenems
  • Aminoglycosides
  • Other


  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

Why AnalystView?


Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials


Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us


We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This